A new study identifies certain neurotoxins responsible for brain inflammation common to early on-set Alzheimer's disease and ...

Growing evidence suggests that the key to treating Alzheimer's is catching it in its earliest stages. Now scientists have ...

Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate ...

The findings add to previous research at CU Anschutz which found that Alzheimer’s patients given Leukine showed improvement ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Northwestern University scientists are developing an experimental drug that could serve as an early intervention for Alzheimer’s disease.

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

Explore the potential of experimental drug NU-9 in early Alzheimer's intervention, targeting toxic amyloid beta forms.

The study found that consistent use of certain widely-prescribed medications for bladder disorders, Parkinson's disease, and ...

New Alzheimer's drug Leqembi offers hope to Oklahoma couple as they celebrate 50 years of marriage and fight against the ...